How to Get Ibogaine Treatment: What the Process Involves

How to get ibogaine treatment, according to the clinic pages we read on 30 October 2026, starts with an application and a medical review, not a booking. The clinics describe a similar order of steps: an application, a conversation with their team, heart and blood tests, a plan for any medications you take, preparation sessions and only then travel. This page walks through those steps as the clinics state them (the clinics read operate in Mexico), what published research says about why the screening matters, and what to ask before you commit to anything. It does not rank or recommend any clinic, and it cannot tell you whether ibogaine is right or safe for you.

The steps clinics describe

Everything in this section is a clinic describing its own process. It is a provider statement, not an independent finding, and details differ from clinic to clinic.

1. Application or pre-screen. IbogaQuest says you complete an online application covering your history, intentions and medical background, and that a team member reviews it within 72 hours and notes any contraindications. MindScape Retreat describes a free, private pre-screen answered by its clinical staff. Beond says you apply through a secure patient portal before booking travel. Ambio and the Iboga Wellness Institute both list an application followed by a talk with an intake team.
2. Medical review. Beond says you speak with one of its physicians before you fly and that physicians decide whether treatment is safe for you. MindScape says its physicians determine eligibility from your history, bloodwork and EKG, and its journey page places the medical review one to two weeks before arrival.
3. Heart and blood tests. IbogaQuest lists blood pressure, an EKG, a complete blood count, a basic metabolic panel, a urine test and a liver function test within three months of the retreat, and says people over 60 or with certain conditions may need more, such as a heart stress test. Ambio and the Iboga Wellness Institute list an EKG within three months of arrival and a blood panel that includes potassium, magnesium and liver enzymes.
4. A plan for your medications. IbogaQuest says strong CYP2D6 blockers such as paroxetine, fluoxetine and bupropion rule out treatment until your own prescriber has tapered them and you are cleared, that methadone and buprenorphine are switched to a shorter-acting medicine well beforehand, and that it postpones or declines if stopping a medicine would be unsafe. Ambio says SSRIs must be tapered and asks for at least 7 days without alcohol before arrival; the Iboga Wellness Institute asks for at least 5. Both IbogaQuest and the Iboga Wellness Institute say not to stop prescribed medicines without medical guidance.
5. Preparation. IbogaQuest describes preparation sessions with a psychotherapist or coach and a deposit that is fully refunded if its medical team later finds treatment unsafe. Ambio and the Iboga Wellness Institute list at least two coaching meetings before arrival.
6. Travel. Ambio and the Iboga Wellness Institute describe pickup in San Diego for transport to the clinic. IbogaQuest says people who need medical detox can arrive up to seven days early at a separate supervised location.

Taken together, these pages describe the same pattern: screening and medication planning come before travel, and a clinic's medical team can decline you.

Who clinics say may be excluded

Clinics publish different lists, and they come from different places. IbogaQuest's safety page separates its own practice from published guidance. It says it declines people with structural heart disease, heart failure, ventricular arrhythmias, unexplained fainting, or a family history of sudden death or congenital long QT, and that strong CYP2D6 blockers rule out treatment until they have been tapered. It then attributes a longer list to a 2016 guideline (Clinical Guidelines for Ibogaine-Assisted Detoxification, Global Ibogaine Therapy Alliance) and a MAPS ibogaine investigator's brochure, which it says exclude or ask for specialist review of people with heart disease or a long resting QTc, uncorrected low potassium or magnesium, significant liver or kidney disease, psychotic illness, treated bipolar disorder or epilepsy, serious lung disease or pregnancy, and people taking medicines that lengthen the QT interval or slow the breakdown of ibogaine. The page adds that some of these rule treatment out while others call for case-by-case weighing by a medical team, and that it does not automatically exclude psychosis, bipolar disorder or epilepsy. We did not read the guideline or the brochure.

Ambio lists certain heart conditions, active psychosis or mania, uncontrolled epilepsy, advanced liver, kidney or lung disease and pregnancy, and says its team may also decide case by case. MindScape lists prolonged QT, severe liver disease, active psychosis, schizophrenia and use of MAOIs or certain psychiatric medications. Some of these are a clinic's own policy and some come from published guidance, the lists differ, and none of them applies to you automatically.

Why screening comes first

A 2026 review in the journal Addiction describes a rare but clinically significant risk to the heart from ibogaine, and recommends that treatment take place only under medical supervision, with CYP2D6 genotyping and close cardiac monitoring. Source: Addiction, 2026 A 2023 systematic review of 12 clinical sources concluded that controlled settings, trained professionals and equipment for medical, psychiatric and cardiac monitoring are essential to safety. Source: Rocha and colleagues, 2023

The evidence for benefit is also limited. A 2026 narrative review of human studies found that most positive results come from uncontrolled, open-label or retrospective studies at high risk of bias, that no double-blind randomized trial has shown ibogaine treats opioid use disorder, and that current evidence is insufficient to support clinical use. Source: Kervadec and colleagues, 2026

Questions to ask before you travel

• What written screening criteria does the clinic use, and who reads the EKG?
• What happens to my deposit if screening rules me out?
• Which of my medicines must change, who supervises the change, and for how long?
• What cardiac monitoring is used during treatment and afterward? The Iboga Wellness Institute, for example, describes continuous monitoring and a repeat EKG within 24 hours.
• What is the plan and the named hospital if something goes wrong? IbogaQuest, for example, states that paramedics and an ambulance are on site on treatment days and names hospitals in Cuernavaca and Cuautla.
• What will I receive in writing, and what follow-up is available once I am home?

For any medical travel, the CDC advises seeing your own clinician or a travel medicine clinician 4 to 6 weeks before the trip, bringing copies of your records, test results and medication list, getting copies of the facility's records before you leave, and confirming you can get follow-up care at home. Source: CDC medical tourism guidance This guidance covers medical travel in general, not ibogaine specifically.

Legal and practical limits

In the United States, ibogaine is listed among the Schedule I hallucinogenic substances in federal regulation. Source: 21 CFR 1308.11 This page does not assess how Mexican law applies to a particular clinic or program. If you want to talk through addiction treatment options in the United States, SAMHSA runs a free, confidential, 24/7 treatment referral and information line at 1-800-662-HELP (4357), in English and Spanish. Source: SAMHSA National Helpline

How this page was made

We read each clinic's public page on 30 October 2026 and recorded only what it states. We did not contact any clinic, receive a fee or referral payment, or verify any clinic's claims. The information here is general and educational; it is not medical advice. Talk with a qualified physician about your own health, including any heart condition or medication you take.